298 related articles for article (PubMed ID: 11259597)
1. Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation.
Melillo RM; Pierantoni GM; Scala S; Battista S; Fedele M; Stella A; De Biasio MC; Chiappetta G; Fidanza V; Condorelli G; Santoro M; Croce CM; Viglietto G; Fusco A
Mol Cell Biol; 2001 Apr; 21(7):2485-95. PubMed ID: 11259597
[TBL] [Abstract][Full Text] [Related]
2. Structure and function of the HMGI(Y) family of architectural transcription factors.
Reeves R
Environ Health Perspect; 2000 Oct; 108 Suppl 5():803-9. PubMed ID: 11035986
[TBL] [Abstract][Full Text] [Related]
3. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation.
Himes SR; Reeves R; Attema J; Nissen M; Li Y; Shannon MF
J Immunol; 2000 Mar; 164(6):3157-68. PubMed ID: 10706706
[TBL] [Abstract][Full Text] [Related]
4. HMGI/Y proteins: flexible regulators of transcription and chromatin structure.
Reeves R; Beckerbauer L
Biochim Biophys Acta; 2001 May; 1519(1-2):13-29. PubMed ID: 11406267
[TBL] [Abstract][Full Text] [Related]
5. A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription.
Foti D; Iuliano R; Chiefari E; Brunetti A
Mol Cell Biol; 2003 Apr; 23(8):2720-32. PubMed ID: 12665574
[TBL] [Abstract][Full Text] [Related]
6. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y).
Brunetti A; Manfioletti G; Chiefari E; Goldfine ID; Foti D
FASEB J; 2001 Feb; 15(2):492-500. PubMed ID: 11156965
[TBL] [Abstract][Full Text] [Related]
8. Interaction between HMGA1 and retinoblastoma protein is required for adipocyte differentiation.
Esposito F; Pierantoni GM; Battista S; Melillo RM; Scala S; Chieffi P; Fedele M; Fusco A
J Biol Chem; 2009 Sep; 284(38):25993-6004. PubMed ID: 19633359
[TBL] [Abstract][Full Text] [Related]
9. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth.
Pierantoni GM; Fedele M; Pentimalli F; Benvenuto G; Pero R; Viglietto G; Santoro M; Chiariotti L; Fusco A
Oncogene; 2001 Sep; 20(43):6132-41. PubMed ID: 11593421
[TBL] [Abstract][Full Text] [Related]
10. Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations.
Tallini G; Dal Cin P; Rhoden KJ; Chiapetta G; Manfioletti G; Giancotti V; Fusco A; Van den Berghe H; Sciot R
Am J Pathol; 1997 Jul; 151(1):37-43. PubMed ID: 9212729
[TBL] [Abstract][Full Text] [Related]
11. Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells.
Reeves R; Edberg DD; Li Y
Mol Cell Biol; 2001 Jan; 21(2):575-94. PubMed ID: 11134344
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins.
Abe N; Watanabe T; Masaki T; Mori T; Sugiyama M; Uchimura H; Fujioka Y; Chiappetta G; Fusco A; Atomi Y
Cancer Res; 2000 Jun; 60(12):3117-22. PubMed ID: 10866296
[TBL] [Abstract][Full Text] [Related]
13. Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status.
Giannini G; Kim CJ; Di Marcotullio L; Manfioletti G; Cardinali B; Cerignoli F; Ristori E; Zani M; Frati L; Screpanti I; Guilino A
Br J Cancer; 2000 Dec; 83(11):1503-9. PubMed ID: 11076660
[TBL] [Abstract][Full Text] [Related]
14. HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors.
Tallini G; Dal Cin P
Adv Anat Pathol; 1999 Sep; 6(5):237-46. PubMed ID: 10472377
[TBL] [Abstract][Full Text] [Related]
15. High mobility group I/Y: multifunctional chromosomal proteins causally involved in tumor progression and malignant transformation (review).
Wisniewski JR; Schwanbeck R
Int J Mol Med; 2000 Oct; 6(4):409-19. PubMed ID: 10998430
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB mediated transcriptional activation is enhanced by the architectural factor HMGI-C.
Mantovani F; Covaceuszach S; Rustighi A; Sgarra R; Heath C; Goodwin GH; Manfioletti G
Nucleic Acids Res; 1998 Mar; 26(6):1433-9. PubMed ID: 9490789
[TBL] [Abstract][Full Text] [Related]
17. CCAAT/enhancer binding protein and nuclear factor-Y regulate adiponectin gene expression in adipose tissue.
Park SK; Oh SY; Lee MY; Yoon S; Kim KS; Kim JW
Diabetes; 2004 Nov; 53(11):2757-66. PubMed ID: 15504955
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function.
Choy L; Derynck R
J Biol Chem; 2003 Mar; 278(11):9609-19. PubMed ID: 12524424
[TBL] [Abstract][Full Text] [Related]
19. Human translocation liposarcoma-CCAAT/enhancer binding protein (C/EBP) homologous protein (TLS-CHOP) oncoprotein prevents adipocyte differentiation by directly interfering with C/EBPbeta function.
Adelmant G; Gilbert JD; Freytag SO
J Biol Chem; 1998 Jun; 273(25):15574-81. PubMed ID: 9624148
[TBL] [Abstract][Full Text] [Related]
20. Specific binding of high-mobility-group I (HMGI) protein and histone H1 to the upstream AT-rich region of the murine beta interferon promoter: HMGI protein acts as a potential antirepressor of the promoter.
Bonnefoy E; Bandu MT; Doly J
Mol Cell Biol; 1999 Apr; 19(4):2803-16. PubMed ID: 10082546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
